Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Dose-dependent change in tissue uptake of 17β-(16α-[125I]iodo)-estradiol in female rats: Application to external imaging of mammary carcinoma

  • 23 Accesses

  • 1 Citations


Recently, many studies have drawn attention to the possibility of imaging estrogen-receptor-positive breast cancer with a high-affinity ligand such as 17β-(16α-[125I]iodo)-estradiol (I-E2). We tried to determine the most suitable time and dose for imaging with this compound, using uteri of mature Sprague-Dawley rats. Although the uptake of I-E2 in the target organ (uterus) reached its peak 1 h after subcutaneous injection, the ratio of uptake in the target organ to that in nontarget organs (lung and muscle) peaked at 4 h. We also found that this ratio decreased as the dose increased. The clearest image was available 4 h after the dose meeting the minimum requirement for imaging was administered. An imaging trial of dimethylbenzanthracene (DMBA)-induced mammary carcinoma is also demonstrated.

This is a preview of subscription content, log in to check access.


  1. 1.

    Arunachalam T, Longcope C, Capsi E (1979) Iodoestrogens, syntheses, and interaction with uterine receptors. J Biol Chem 254:5900–5905

  2. 2.

    Eckelman WC, Reba RC, Gibson RE, Rzeszotarski WJ, Vieras F, Mazaitis JK, Francis B (1981) Receptorbinding radiotracers: A class of potential radiopharmaceuticals. J Nucl Med 20:350–357

  3. 3.

    Gatley SJ, Shaughnessy WJ, Inhorn L, Lieberman LM (1981) Studies with 17β(16α-[125I]iodo)estradiol, an estrogen receptorbinding radiopharmaceutical, in rats bearing mammary tumors. J Nucl Med 22:459–464

  4. 4.

    Hochberg RB (1979) Iodo-125-labeled estradiol: A gammaemitting analog of estradiol that binds to the estrogen receptor. Science 205:1138–1140

  5. 5.

    Hochberg RB, Rosner W (1980) Interaction of 16α-[125I]iodoestradiol with estrogen receptor and other binding proteins. Proc Natl Acad Sci USA 77:328–332

  6. 6.

    Katzenellenbogen JA, Hsiung HM, Carlson KE, McGuire WL, Kraay RJ, Katzenellenbogen BS (1975) Characterization of the binding and estrogenic activity of iodinated hexestrol derivatives, in vitro and in vivo. Biochemistry 14:1742–1749

  7. 7.

    Katzenellenbogen JA, Senderoff SG, McElvany KD, O'Brien HA, Welch MJ (1981) 16α-[77Br]bromoestradiol-17: A high specific activity, gamma-emitting tracer with uptake in rat uterus and induced mammary tumors. J Nucl Med 22:42–47

  8. 8.

    Knight WA, Livingston RB, Gregory EJ, McGuire WL (1979) Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37:4669–4671

  9. 9.

    Longcope C, Arunachalam T, Rafkind I, Capsi E (1981) Biological activity of 125I and 127I estradiol analogs in vitro and in vivo. J Steroid Biochem 14:261–269

  10. 10.

    McElvany KD, Carlson KE, Welch MJ, Senderoff SG, Katzenellenbogen JA, the Los Alamos Medical Radioisotope Group (1982) In vivo comparison of 16α-[77Br]bromo-estradiol-17β and 16α-[125I]iodo-estradiol-17β. J Nucl Med 23:420–424

  11. 11.

    McGuire WL, Carbone PP, Vollmer PP (1975) Estrogen receptors in human breast cancer. Raven Press, New York

  12. 12.

    Mazaitis JK, Gibson RE, Komai T, Eckelman WC, Francis B, Reba RC (1980) Radioiodinated estrogen derivatives. J Nucl Med 21:142–146

  13. 13.

    Ratajczak T, Sheppard PN, Capon RJ, Hähnel R (1981) The synthesis and study of some potential affinity labeling reagents. Steroids 38:537–555

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Noguchi, S., Koyama, H. & Nakano, S. Dose-dependent change in tissue uptake of 17β-(16α-[125I]iodo)-estradiol in female rats: Application to external imaging of mammary carcinoma. Eur J Nucl Med 9, 490–493 (1984).

Download citation


  • Breast Cancer
  • Estradiol
  • Target Organ
  • Minimum Requirement
  • Mammary Carcinoma